PAIN MANAGEMENT OPTIMA, MODEL PMO21-100-05, PMO20-100-10CS, PMO20-145-10CS— 510(k) K092337

Name: FDA 510(k) clearance K092337
Creator: U.S. Food and Drug Administration
Published: 2009-10-16

Substantially Equivalent

Baylis Medical Co., Inc.

FDA 510(k) clearance K092337 for PAIN MANAGEMENT OPTIMA, MODEL PMO21-100-05, PMO20-100-10CS, PMO20-145-10CS, Substantially Equivalent on 2009-10-16. Applicant: Baylis Medical Co., Inc.. Device class: 2.

Clearance details

Applicant: Baylis Medical Co., Inc.
Product code: Code GXI
Device class: Class 2
Regulation: 21 CFR 882.4725
Advisory panel: Neurology
Date received: 2009-08-04
Decision date: 2009-10-16
Decision: Substantially Equivalent
Clearance type: Special
Location: Mississauga, Ontario, CA

Download summary PDF View on FDA.gov ↗

Recent devices under product code GXI

view all

K253907 — Disposable Radiofrequency Cannula2026-04-16
K251802 — STAR RF Ablation System2026-02-13
K251243 — OneRF Trigeminal Nerve Radiofrequency Probes2025-08-15
K242841 — Disposable RF Electrode (RFDE-5/RFDE-10/RFDE-15/RFDE-20)2025-05-27
K250213 — OptaBlate BVN Intraosseous Nerve Ablation System (10mm Probe Single Kit) +1 more2025-05-15

More clearances from Baylis Medical Co., Inc.

view all

K122926 — SUREFLEX STEERABLE GUIDING SHEATH KIT2013-01-24
K111523 — OSTEOCOOL (TM) RF ABLATION SYSTEM2012-03-13
K102948 — TORFLEX TRANSSEPTAL GUIDING SHEATH2011-04-01
K102192 — INDISCAL DIGITAL MANOMETER2011-02-23
K101372 — DUOCOOL PAIN MANAGEMENT PROBE, MODEL OSP-17-180-202010-08-10

Adverse events under product code GXI

product code GXI

Death: 3
Injury: 171
Total: 174

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.